Targeting metastatic castration-resistant prostate cancer: mechanisms of progression and novel early therapeutic approaches
Author:
Publisher
Informa Healthcare
Subject
Pharmacology (medical),Pharmacology,General Medicine
Link
http://www.tandfonline.com/doi/pdf/10.1517/13543784.2014.885950
Reference130 articles.
1. Cancer statistics, 2012
2. Cancer mortality in Europe, 2000–2004, and an overview of trends since 1975
3. Bypass Mechanisms of the Androgen Receptor Pathway in Therapy-Resistant Prostate Cancer Cell Models
4. Gene Expression Analysis of Human Prostate Carcinoma during Hormonal Therapy Identifies Androgen-Responsive Genes and Mechanisms of Therapy Resistance
5. Castration-Recurrent Prostate Cancer Is Not Androgen-Independent
Cited by 20 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. RNA aptamer-mediated gene therapy of prostate cancer: lessons from the past and future directions;Expert Opinion on Drug Delivery;2023-11-02
2. Aptamers in biosensing: biological characteristics and applications;Aptamers Engineered Nanocarriers for Cancer Therapy;2023
3. Therapeutic potential of targeting mirnas to prostate cancer tumors: using psma as an active target;Molecular & Cellular Oncology;2022-10-24
4. The Role of Histology-Agnostic Drugs in the Treatment of Metastatic Castration-Resistant Prostate Cancer;International Journal of Molecular Sciences;2022-08-01
5. Prostate-Specific Membrane Antigen-Targeted Turn-on Probe for Imaging Cargo Release in Prostate Cancer Cells;Bioconjugate Chemistry;2021-10-26
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3